RT Journal Article
SR Electronic
T1 Post-discharge health status and symptoms in patients with severe COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.11.20172742
DO 10.1101/2020.08.11.20172742
A1 Himali Weerahandi
A1 Katherine A. Hochman
A1 Emma Simon
A1 Caroline Blaum
A1 Joshua Chodosh
A1 Emily Duan
A1 Kira Garry
A1 Tamara Kahan
A1 Savannah Karmen-Tuohy
A1 Hannah C. Karpel
A1 Felicia Mendoza
A1 Alexander M. Prete
A1 Lindsey Quintana
A1 Jennifer Rutishauser
A1 Leticia Santos Martinez
A1 Kanan Shah
A1 Sneha Sharma
A1 Elias Simon
A1 Ana Stirniman
A1 Leora I. Horwitz
YR 2020
UL http://medrxiv.org/content/early/2020/08/14/2020.08.11.20172742.abstract
AB Background Little is known about long-term recovery from severe COVID-19 disease. Here, we characterize overall health, physical health and mental health of patients one month after discharge for severe COVID-19.Methods This was a prospective single health system observational cohort study of patients ≥18 years hospitalized with laboratory-confirmed COVID-19 disease who required at least 6 liters of oxygen during admission, had intact baseline cognitive and functional status and were discharged alive. Participants were enrolled between 30 and 40 days after discharge. Outcomes were elicited through validated survey instruments: the PROMIS® Dyspnea Characteristics and PROMIS® Global Health-10.Results A total of 161 patients (40.6% of eligible) were enrolled; 152 (38.3%) completed the survey. Median age was 62 years (interquartile range [IQR], 50-67); 57 (37%) were female. Overall, 113/152 (74%) participants reported shortness of breath within the prior week (median score 3 out of 10 [IQR 0-5]), vs. 47/152 (31%) pre-COVID-19 infection (0, IQR 0-1), p<0.001. Participants also rated their physical health and mental health as worse in their post-COVID state (43.8, standard deviation 9.3; mental health 47.3, SD 9.3) compared to their pre-COVID state, (54.3, SD 9.3; 54.3, SD 7.8, respectively), both p <0.001. A total of 52/148 (35.1%) patients without pre-COVID oxygen requirements needed home oxygen after hospital discharge; 20/148 (13.5%) reported still using oxygen at time of survey.Conclusions Patients with severe COVID-19 disease typically experience sequelae affecting their respiratory status, physical health and mental health for at least several weeks after hospital discharge.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received specifically for this study. Dr. Weerahandi is supported by a grant from the National Heart, Lung, and Blood Institute, National Institutes of Health (K23HL145110). The National Institutes of Health had no role in design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review or approval of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The NYU Grossman School of Medicine Institutional Review Board approved the protocol.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDeidentified data may be available upon request to the authors.